论文部分内容阅读
目的:探讨难治性支原体肺炎患儿临床治疗中糖皮质激素的应用效果。方法:选取2013年1月至2014年3月我院收治的难治性支原体肺炎患儿80例,随机分为两组,对照组40例,主要采用阿奇霉素和头孢地嗪结合治疗,观察组40例,在对照组治疗基础上采用甲泼尼龙药物治疗,对比两组治疗效果。结果:经过治疗,观察组药物治疗有效率为97.5%明显高于对照组的80.0%(P<0.05),且观察组临床症状改善时间明显短于对照组(P<0.05);在炎症相关指标上,观察组明显优于对照组,差异具有统计学意义(P<0.05)。结论:在难治性支原体肺炎患儿临床治疗中,糖皮质激素的应用效果较好。
Objective: To investigate the clinical effect of glucocorticoid in children with refractory mycoplasma pneumonia. Methods: Totally 80 children with refractory mycoplasma pneumonia admitted in our hospital from January 2013 to March 2014 were randomly divided into two groups. The control group consisted of 40 patients, mainly treated with azithromycin and cefodizime. The observation group 40 Cases, in the control group based on the use of methylprednisolone drug treatment, the two groups compared the therapeutic effect. Results: After treatment, the effective rate of medication in the observation group was 97.5%, which was significantly higher than that in the control group (80.0%, P <0.05), and the clinical symptom improvement time in the observation group was significantly shorter than that in the control group (P <0.05) , The observation group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: The application of glucocorticoids is better in the clinical treatment of children with refractory mycoplasma pneumonia.